Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate

Such a result is significant not only to the Companys ongoing clinical research, but could have tremendous effects on cancer treatments worldwide.